International Business Machines Valuation
Is IBM undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of IBM when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: IBM (CHF135) is trading below our estimate of fair value (CHF216.59)
Significantly Below Fair Value: IBM is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for IBM?
Other financial metrics that can be useful for relative valuation.
What is IBM's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$180.51b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 3.6x |
Enterprise Value/EBITDA | 15.5x |
PEG Ratio | 4.3x |
Price to Earnings Ratio vs Peers
How does IBM's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 30.1x | ||
ACN Accenture | 29.8x | 10.7% | US$209.0b |
TCS Tata Consultancy Services | 34.5x | 9.7% | ₹16.3t |
INFY Infosys | 28.7x | 7.2% | ₹7.8t |
HCLTECH HCL Technologies | 27.3x | 8.4% | ₹4.5t |
IBM International Business Machines | 21.5x | 5.0% | CHF 180.5b |
Price-To-Earnings vs Peers: IBM is good value based on its Price-To-Earnings Ratio (21.5x) compared to the peer average (30.1x).
Price to Earnings Ratio vs Industry
How does IBM's PE Ratio compare vs other companies in the European IT Industry?
Price-To-Earnings vs Industry: IBM is expensive based on its Price-To-Earnings Ratio (21.5x) compared to the European IT industry average (20.1x).
Price to Earnings Ratio vs Fair Ratio
What is IBM's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 21.5x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate IBM's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | CHF 135.00 | CHF 161.15 +19.4% | 13.7% | CHF 189.79 | CHF 111.14 | n/a | 19 |
Aug ’25 | CHF 135.00 | CHF 163.59 +21.2% | 14.2% | CHF 194.84 | CHF 114.10 | n/a | 19 |
Jul ’25 | CHF 135.00 | CHF 160.60 +19.0% | 13.4% | CHF 192.01 | CHF 116.10 | n/a | 19 |
Jun ’25 | CHF 135.00 | CHF 163.14 +20.8% | 13.9% | CHF 194.61 | CHF 117.67 | n/a | 18 |
May ’25 | CHF 135.00 | CHF 168.47 +24.8% | 12.9% | CHF 197.62 | CHF 119.49 | n/a | 18 |
Apr ’25 | CHF 135.00 | CHF 168.11 +24.5% | 15.6% | CHF 202.53 | CHF 113.02 | n/a | 18 |
Mar ’25 | CHF 135.00 | CHF 160.26 +18.7% | 15.2% | CHF 198.41 | CHF 110.72 | n/a | 19 |
Feb ’25 | CHF 135.00 | CHF 153.11 +13.4% | 16.3% | CHF 192.13 | CHF 107.21 | n/a | 19 |
Jan ’25 | CHF 135.00 | CHF 127.50 -5.6% | 14.9% | CHF 176.63 | CHF 92.52 | n/a | 17 |
Dec ’24 | CHF 135.00 | CHF 131.71 -2.4% | 11.2% | CHF 160.93 | CHF 98.89 | n/a | 16 |
Nov ’24 | CHF 135.00 | CHF 131.43 -2.6% | 11.3% | CHF 160.99 | CHF 98.94 | n/a | 16 |
Oct ’24 | CHF 135.00 | CHF 132.06 -2.2% | 12.0% | CHF 169.03 | CHF 98.90 | n/a | 16 |
Sep ’24 | CHF 135.00 | CHF 126.93 -6.0% | 10.3% | CHF 153.76 | CHF 96.65 | n/a | 15 |
Aug ’24 | CHF 135.00 | CHF 124.38 -7.9% | 10.0% | CHF 150.51 | CHF 94.60 | CHF 135.00 | 16 |
Jul ’24 | CHF 135.00 | CHF 126.16 -6.5% | 8.4% | CHF 146.67 | CHF 99.59 | CHF 135.00 | 14 |
Jun ’24 | CHF 135.00 | CHF 123.51 -8.5% | 8.3% | CHF 144.18 | CHF 97.90 | CHF 135.00 | 14 |
May ’24 | CHF 135.00 | CHF 124.68 -7.6% | 8.3% | CHF 144.79 | CHF 98.32 | CHF 135.00 | 14 |
Apr ’24 | CHF 135.00 | CHF 133.97 -0.8% | 9.0% | CHF 153.23 | CHF 102.15 | CHF 135.00 | 15 |
Mar ’24 | CHF 135.00 | CHF 131.46 -2.6% | 8.9% | CHF 149.94 | CHF 99.96 | CHF 135.00 | 15 |
Feb ’24 | CHF 135.00 | CHF 131.46 -2.6% | 8.9% | CHF 149.94 | CHF 99.96 | CHF 135.00 | 15 |
Jan ’24 | CHF 135.00 | CHF 133.05 -1.4% | 9.2% | CHF 155.67 | CHF 104.73 | CHF 135.00 | 15 |
Dec ’23 | CHF 135.00 | CHF 139.18 +3.1% | 8.5% | CHF 158.67 | CHF 110.08 | CHF 135.00 | 15 |
Nov ’23 | CHF 135.00 | CHF 139.18 +3.1% | 8.5% | CHF 158.67 | CHF 110.08 | CHF 135.00 | 15 |
Oct ’23 | CHF 135.00 | CHF 139.68 +3.5% | 8.9% | CHF 159.11 | CHF 109.33 | CHF 135.00 | 15 |
Sep ’23 | CHF 135.00 | CHF 139.59 +3.4% | 7.7% | CHF 157.53 | CHF 114.04 | CHF 135.00 | 15 |
Aug ’23 | CHF 135.00 | CHF 137.47 +1.8% | 7.5% | CHF 154.07 | CHF 113.63 | CHF 135.00 | 17 |
Analyst Forecast: Target price is lower than the current share price.